Single‐cell dynamics of chromatin activity during cell lineage differentiation in Caenorhabditis elegans embryos

Elucidating the chromatin dynamics that orchestrate embryogenesis is a fundamental question in developmental biology. Here, we exploit position effects on expression as an indicator of chromatin activity and infer the chromatin activity landscape in every lineaged cell during Caenorhabditis elegans early embryogenesis. Systems‐level analyses reveal that chromatin activity distinguishes cellular states and correlates with fate patterning in the early embryos. As cell lineage unfolds, chromatin activity diversifies in a lineage‐dependent manner, with switch‐like changes accompanying anterior–posterior fate asymmetry and characteristic landscapes being established in different cell lineages. Upon tissue differentiation, cellular chromatin from distinct lineages converges according to tissue types but retains stable memories of lineage history, contributing to intra‐tissue cell heterogeneity. However, the chromatin landscapes of cells organized in a left–right symmetric pattern are predetermined to be analogous in early progenitors so as to pre‐set equivalent states. Finally, genome‐wide analysis identifies many regions exhibiting concordant chromatin activity changes that mediate the co‐regulation of functionally related genes during differentiation. Collectively, our study reveals the developmental and genomic dynamics of chromatin activity at the single‐cell level.     

Transmission of synovial sarcoma from a single multi-organ donor to three transplant recipients: case report

Quick and reliable testing of EGFR and KRAS is needed in non-small cell lung cancer (NSCLC) to ensure optimal decision-making for targeted therapy. The Idylla™ platform was designed for Formalin-Fixed Paraffin-Embedded (FFPE) tissue sections but recently several studies were published that evaluated its potential for cytological specimens. This study aimed to validate the Idylla™ platform for the detection of EGFR/KRAS mutations in cytological NSCLC samples prepared as cytoblocks using AGAR and paraffin embedding. The KRAS Idylla™ test were performed on 11 specimens with a known KRAS mutation. The EGFR Idylla™ test was performed on 18 specimens with a known primary EGFR mutation and 7 specimens with a primary EGFR-EGFR T790M resistance mutation combination. Concordant KRAS and primary EGFR mutations were detected for both KRAS and primary EGFR mutations. Samples with a total CQ value of < 26 could be considered negative. Samples with a total CQ value of > 26 could not be assessed (probability of false-negative). In specimens with a primary EGFR-EGFR T790M resistance mutation combination, 5/7 cases were not concordant. Our results confirm the conclusion of recent reports that the Idylla™EGFR assay is not suitable in a resistance to EGFR TKI setting, also not in our cytological NSCLC samples prepared as cytoblocks using AGAR and paraffin embedding. KRAS and primary EGFR mutations were detected using the Idylla™ assays in virtually all cytological NSCLC samples. This analysis was rapid and time-saving compared to other mutation detection assays and may be useful if the amount of material is insufficient to perform a full set of molecular tests.     

Effects of pulse precipitation on soil organic matter mineralization in forests: spatial variation and controlling factors

脉冲降水对森林中土壤有机物矿化的影响：空间变化和控制因素 降水脉冲效应使土壤有机物在短时间内迅速分解并释放大量CO₂到大气中。降水脉冲效应对生态系统的碳循环和土壤碳平衡的研究具有十分重要的意义,但它在森林土壤中的空间变化和基本机制仍不清楚。我们采集中国东部22个典型森林生态系统的土壤样品(0–10cm),研究模拟脉冲降水对土壤微生物呼吸速率的影响。模拟降水脉冲使土壤样品达到65%饱和含水量,以分钟为单位测量R_s,持续48 小时。研究结果显示,降水脉冲可以使微生物呼吸速率迅速增加1.70–38.12倍。微生物最大呼吸速率 (R_s-soil-max)、碳释放总量R_s (A_Rs-soil)和达到呼吸峰值的时间(T_Rs-soil-max)在不同的土壤中存在显著差异。此外,不同 气候区的脉冲效应也有明显不同。中温带的R_s-soil-max (11.701 µg C g⁻¹ soil h⁻¹)和A_Rs-soil (300.712 µg C g⁻¹ soil)最高。土壤化学特性(总碳和总氮、pH值和氧化还原电位)和土壤粒径与森林土壤的脉冲效应密切相关,但土壤微生物的贡献较小。我们的研究结果表明,在大尺度范围内,脉冲变化短期内增加森林土壤中CO₂的排放,并揭示了对这种变化影响最大的因素。这些发现为未来对森林生态系统的碳循环和调节全球生态系统碳循环的研究提供科学数据支持。     

A new Illumina MiSeq high-throughput sequencing-based method for evaluating the composition of the Bacteroides community in the intestine using the rpsD gene sequence

Bacteroides is a bacterial genus that is known to closely interact with the host. The potential role of this genus is associated with its ecological status and distribution in the intestine. However, the current 16S V3–V4 region sequencing method can only detect the abundance of this genus, revealing a need for a novel sequencing method that can elucidate the composition of Bacteroides in the human gut microbiota. In this study, a core gene, rpsD, was selected as a template for the design of a Bacteroides-specific primer set. We used this primer set to develop a novel assay based on the Illumina MiSeq sequencing platform that enabled an accurate assessment of the Bacteroides compositions in complex samples. Known amounts of genomic DNA from 10 Bacteroides species were mixed with a complex sample and used to evaluate the performance and detection limit of our assay. The results were highly consistent with those of direct sequencing with a low Bacteroides DNA detection threshold (0.01 ng), supporting the reliability of our assay. In addition, the assay could detect all the known Bacteroides species within the faecal sample. In summary, we provide a sensitive and specific approach to determining the Bacteroides species in complex samples.     

Multifaceted roles of duckweed in aquatic phytoremediation and bioproducts synthesis

Duckweed (Lemnaceae) is a fast‐growing aquatic vascular plant. It has drawn an increasing attention worldwide due to its application in value‐added nutritional products and in sewage disposal. In particular, duckweed is a promising feedstock for bioenergy production. In this review, we summarized applications of duckweed from the following four aspects. Firstly, duckweed could utilize nitrogen, phosphorus, and inorganic nutrition in wastewater and reduces water eutrophication efficiently. During these processes, microorganisms play an important role in promoting duckweed growth and improving its tolerance to stresses. We also introduced our pilot‐scale test using duckweed for wastewater treatment and biomass production simultaneously. Secondly, its capability of fast accumulation of large amounts of starch makes duckweed a promising bioenergy feedstock, catering the currently increasing demand for bioethanol production. Pretreatment conditions prior to fermentation can be optimized to improve the conversion efficiency from starch to bioethanol. Furthermore, duckweed serves as an ideal source for food supply or animal feed because the composition of amino acids in duckweed is similar to that of whey protein, which is easily digested and assimilated by human and other animals. Finally, severing as a natural plant factory, duckweed has shown great potential in the production of pharmaceuticals and dietary supplements. With the surge of omics data and the development of Clustered Regularly Interspaced Short Palindromic Repeats technology, remodeling of the metabolic pathway in duckweed for synthetic biology study will be attainable in the future.     

Benchmarking and optimization of a high-throughput sequencing based method for transgene sequence variant analysis in biotherapeutic cell line development

In recent years, High-Throughput Sequencing (HTS) based methods to detect mutations in biotherapeutic transgene products have become a key quality step deployed during the development of manufacturing cell line clones. Previously we reported on a higher throughput, rapid mutation detection method based on amplicon sequencing (targeting transgene RNA) and detailed its implementation to facilitate cell line clone selection. By gaining experience with our assay in a diverse set of cell line development programs, we improved the computational analysis as well as experimental protocols. Here we report on these improvements as well as on a comprehensive benchmarking of our assay. We evaluated assay performance by mixing amplicon samples of a verified mutated antibody clone with a non-mutated antibody clone to generate spike-in mutations from ∼60% down to ∼0.3% frequencies. We subsequently tested the effect of 16 different sample and HTS library preparation protocols on the assay's ability to quantify mutations and on the occurrence of false-positive background error mutations (artifacts). Our evaluation confirmed assay robustness, established a high confidence limit of detection of ∼0.6%, and identified protocols that reduce error levels thereby significantly reducing a source of false positives that bottlenecked the identification of low-level true mutations.     

Middle Jurassic radiolarians from Jinlang,Zedong, southern Xizang (Tibet), China

Moderately to well-preserved radiolarians have been extracted from nine greyish green and purplish-red bedded cherts in the mud-matrix mélange of the eastern Yarlung-Zangbo Suture Zone (YZSZ) at Jinlang Section, Zedong, southern Xizang (Tibet). Forty-two species belonging to 27 genera, including Middle Jurassic characteristic species such as Laxtorum (?) jurassicum Isozaki and Matsuda, Laxtorum (?) hichisoense Isozaki and Matsuda, Stichocapsa japonica Yao, Stichocapsa robusta Matsuoka, Parahsuum (?) magnum Takemura, Sella chrafatensis (El Kadiri), and Unuma typicus Ichikawa and Yao are recognized and three assemblages, Laxtorum (?) jurassicum Assemblage (Aalenian), Quarticella ovalis Assemblage (late Bajocian), and Stichocapsa robusta Assemblage (middle Bathonian) are established in ascending order. These assemblages can be well correlated to the Middle Jurassic Unitary Association (UA) Zones (Baumgartner et al., 1995) in west Tethys and coeval biozones in Japan and provide reliable age information for the Middle Jurassic stratigraphic correlation of the pelagic sediments along the YZSZ.     

Efficacy of RyR2 inhibitor EL20 in induced pluripotent stem cell-derived cardiomyocytes from a patient with catecholaminergic polymorphic ventricular tachycardia

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited cardiac arrhythmia syndrome that often leads to sudden cardiac death. The most common form of CPVT is caused by autosomal-dominant variants in the cardiac ryanodine receptor type-2 (RYR2) gene. Mutations in RYR2 promote calcium (Ca²⁺) leak from the sarcoplasmic reticulum (SR), triggering lethal arrhythmias. Recently, it was demonstrated that tetracaine derivative EL20 specifically inhibits mutant RyR2, normalizes Ca²⁺ handling and suppresses arrhythmias in a CPVT mouse model. The objective of this study was to determine whether EL20 normalizes SR Ca²⁺ handling and arrhythmic events in induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) from a CPVT patient. Blood samples from a child carrying RyR2 variant RyR2 variant Arg-176-Glu (R176Q) and a mutation-negative relative were reprogrammed into iPSCs using a Sendai virus system. iPSC-CMs were derived using the Stemdiff^TM kit. Confocal Ca²⁺ imaging was used to quantify RyR2 activity in the absence and presence of EL20. iPSC-CMs harbouring the R176Q variant demonstrated spontaneous SR Ca²⁺ release events, whereas administration of EL20 diminished these abnormal events at low nanomolar concentrations (IC₅₀ = 82 nM). Importantly, treatment with EL20 did not have any adverse effects on systolic Ca²⁺ handling in control iPSC-CMs. Our results show for the first time that tetracaine derivative EL20 normalized SR Ca²⁺ handling and suppresses arrhythmogenic activity in iPSC-CMs derived from a CPVT patient. Hence, this study confirms that this RyR2-inhibitor represents a promising therapeutic candidate for treatment of CPVT.     

Anti-inflammatory mechanisms and research progress of colchicine in atherosclerotic therapy

Inflammatory responses play a vital role in the onset and development of atherosclerosis, and throughout the entire process of the chronic disease. The inflammatory responses in atherosclerosis are mainly mediated by the NLRP3 inflammasome and its downstream inflammatory factors. As a powerful anti-inflammatory medicine, colchicine has a history of more than 200 years in clinical application and is the first-choice treatment for immune diseases such as gout and familial Mediterranean fever. In atherosclerosis, colchicine can inhibit the assembly and activation of NLRP3 inflammasome via various mechanisms to effectively reduce the expression of inflammatory factors, thereby reducing the inflammation. Recent clinical trials show that a low dose of colchicine (0.5 mg per day) has a certain protective effect in stable angina patients or those with acute myocardial infarction after PCI. This article summarizes and discusses the mechanisms of colchicine in the treatment of atherosclerosis and the latest research progress.